MNOV

MediciNova Inc.

Price

$3.55

return (12m)

179.49%

p/e

-16.25

p/bv

4.69

DIVIDEND YIELD

0.00%

MNOV price

MediciNova

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment MNOV

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

156.28%

3 months

168.90%

1 year

179.49%

2 years

110.03%

5 years

-7.08%

10 years

-49.79%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals MNOV

Valuation

P/E

-16.25

Sector -3.50

Industry -3.50

P/BV

4.69

Sector 2.02

Industry 2.02

P/Revenue (PSR)

227.49

Sector 2.01

Industry 2.01

EV/EBITDA

-58.87

Sector -214.99

Industry -214.99

EV/EBIT

-58.75

Sector -47.59

Industry -47.59

P/EBITDA

-14.77

Sector -21.41

Industry -21.41

P/EBIT

-14.74

Sector -28.65

Industry -28.65

P/Total Assets

4.32

Sector 1.19

Industry 1.19

P/Net Current Assets

7.68

Sector -11.97

Industry -11.97

P/Working Capital

7.61

Sector -167.95

Industry -167.95

EPS

-0.22

Sector -1.81

Industry -1.81

BVPS

0.76

Sector 2.06

Industry 2.06

Efficiency

Gross Margin

44.66%

Sector 41.30%

Industry 41.30%

EBITDA Margin

-553.71%

Sector -17,117.21%

Industry -17,117.21%

EBIT Margin

-554.80%

Sector -4,185,659.35%

Industry -4,185,659.35%

Operating Margin

-100.00%

Sector -35.21%

Industry -35.21%

Net Profit Margins

-100.00%

Sector -35.91%

Industry -35.91%

Asset Turnover

0.01

Sector 0.02

Industry 0.02

Profitability

ROE

-28.85%

Sector -56.04%

Industry -56.04%

ROA

-26.59%

Sector -60.31%

Industry -60.31%

ROIC

-68.26%

Sector -2,335.95%

Industry -2,335.95%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

8.75

Sector 2.89

Industry 2.89

Net Debt / EBITDA

10.02

Sector -14,066,680.10

Industry -14,066,680.10

Net Debt / EBIT

10.00

Sector -8.06

Industry -8.06

Net Debt / Equity

-0.68

Sector -33,024.69

Industry -33,024.69

Gross Debt / Equity

0.00

Sector -0.85

Industry -0.85

Equity/Assets

0.92

Sector 0.46

Industry 0.46

Liabilities/Assets

0.08

Sector 0.41

Industry 0.41

Growth

5Y Revenue CAGR

-28.25%

Sector -

Industry -

5Y Earnings CAGR

1.19%

Sector -

Industry -

Fundamentals MNOV

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
MNOV MediciNova Inc.	$3.55	190.94%	0.00%	-16.25	4.69	-28.85%	-100.00%
JNJ Johnson & Johnson	$269.33	55.44%	1.96%	30.82	7.63	24.76%	21.48%
PFE Pfizer Inc.	$27.49	22.33%	6.26%	35.85	1.83	5.11%	6.86%
ABBV AbbVie Inc.	$263.93	23.34%	2.59%	73.99	-78.76	-106.44%	9.81%
NVO Novo Nordisk A/S	$43.19	-26.70%	4.29%	10.56	5.61	53.11%	35.32%
MRK Merck & Co. Inc.	$146.11	87.14%	2.31%	113.21	8.55	7.55%	4.76%
AZN AstraZeneca PLC	$166.35	9.78%	1.94%	19.88	5.12	25.77%	16.95%
BMY Bristol-Myers Squibb Company	$62.71	43.77%	4.04%	13.67	5.68	41.55%	18.85%
ZTS Zoetis Inc.	$72.66	-49.60%	2.88%	11.47	9.64	84.02%	27.77%
AMGN Amgen Inc.	$383.04	43.28%	2.60%	23.66	17.70	74.80%	22.95%
REGN Regeneron Pharmaceuticals Inc.	$784.44	31.54%	0.47%	18.63	2.54	13.65%	27.86%
HALO Halozyme Therapeutics Inc.	$111.35	46.87%	0.00%	31.57	90.97	288.13%	24.86%
MCK McKesson Corporation	$874.67	27.00%	0.38%	19.57	-26.84	-137.16%	1.29%
VRTX Vertex Pharmaceuticals Incorporated	$506.08	30.72%	0.00%	29.15	6.34	21.76%	35.00%
CAH Cardinal Health Inc.	$224.45	52.89%	0.91%	30.53	-19.32	-63.29%	0.68%
ARGX argenx SE	$994.44	35.42%	0.00%	2.24	2.63	117.11%	44.68%
HRMY Harmony Biosciences Holdings Inc.	$42.23	31.71%	0.00%	13.50	2.45	18.14%	18.88%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

MNOV Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT MediciNova

MediciNova Inc.

Average Investor10 user rating

4.0 (0 people)

United States

26 years

Founded: 2000

2006

Time since IPO - 20 years

11

Employees

MediciNova Inc. (United States) is listed on the Nasdaq and has a market capitalization of $174.71 million, with shareholders equity totaling $37.27 million.

The company employs approximately 11 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, MediciNova Inc. reported $768.00 Thousand in revenue, generating net income of $-10.75 million.

Key financial metrics include a P/E ratio of -16.25, a price-to-book (P/B) ratio of 4.69, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker MNOV.

Market cap

$174.71 million

Net worth

$37.27 million

$37,271,000.00

Assets

$40.43 million

$40,433,000.00

Total Shares Outstanding

49.22 million

49,221,000

Average Daily Trading Volume

$255.25 Thousand

$255,252.54

Sector

Health Care

Industry

Biotechnology

MNOV

MNOV revenue and profits

Financial Results MNOV

DRAG THE FRAME TO SEE MORE DATA

MNOV cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$874.67 25,76% (12M)

P/E

19.57

0.38%

ROE

-137.16%

P/BV

-26.84

CAH - Cardinal Health

$224.45 51,61% (12M)

P/E

30.53

0.91%

ROE

-63.29%

P/BV

-19.32

JNJ - Johnson & Johnson

$269.33 56,33% (12M)

P/E

30.82

1.96%

ROE

24.76%

P/BV

7.63

ABBV - AbbVie

$263.93 22,42% (12M)

P/E

73.99

2.59%

ROE

-106.44%

P/BV

-78.76

MRK - Merck & Co.

$146.11 85,19% (12M)

P/E

113.21

2.31%

ROE

7.55%

P/BV

8.55

AZN - AstraZeneca

$166.35 9,17% (12M)

P/E

19.88

1.94%

ROE

25.77%

P/BV

5.12

PFE - Pfizer

$27.49 22,43% (12M)

P/E

35.85

6.26%

ROE

5.11%

P/BV

1.83

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$874.67 25,76% (12 M)

P/L

19.57

0.38%

ROE

-137.16%

P/VP

-26.84

CAH - Cardinal Health

$224.45 51,61% (12 M)

P/L

30.53

0.91%

ROE

-63.29%

P/VP

-19.32

JNJ - Johnson & Johnson

$269.33 56,33% (12 M)

P/L

30.82

1.96%

ROE

24.76%

P/VP

7.63

ABBV - AbbVie

$263.93 22,42% (12 M)

P/L

73.99

2.59%

ROE

-106.44%

P/VP

-78.76

MRK - Merck & Co.

$146.11 85,19% (12 M)

P/L

113.21

2.31%

ROE

7.55%

P/VP

8.55

AZN - AstraZeneca

$166.35 9,17% (12 M)

P/L

19.88

1.94%

ROE

25.77%

P/VP

5.12

PFE - Pfizer

$27.49 22,43% (12 M)

P/L

35.85

6.26%

ROE

5.11%

P/VP

1.83

Frequently Asked Questions

What is the price of MediciNova (MNOV) today?

A cotação de MediciNova (MNOV) hoje está em US$ 3.55, com uma variação de 179.49% em relação ao último ano. A cotação de MediciNova (MNOV) iniciou o ano negociando na casa dos US$ 1.31 e hoje está em US$ 3.55. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de MediciNova (MNOV) e dados de ações do Ibovespa e mercados internacionais.

Quando MediciNova (MNOV) paga dividendos?

MediciNova (MNOV) não distribuiu dividendos no último ano.

Is MediciNova (MNOV) a good investment?

Atualmente, MediciNova (MNOV) está cotada a US$ 3.55, com um P/L de -16.25, representando um desvio de -940% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 179.49 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 179.49%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy MediciNova (MNOV) stock?

Investir em ações de MediciNova (MNOV) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of MediciNova (MNOV) yield today?

A rentabilidade de MediciNova (MNOV) foi de 156.28% no último mês, 179.49% no último ano e -7.08% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de MediciNova (MNOV) hoje, o investimento total seria de US$ 354.95, com base na cotação atual de US$ 3.55.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 992.05
Em 5 anos: US$ 329.82
Em 10 anos: US$ 178.22

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

MNOV

MediciNova Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment MNOV

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING MNOV WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT MediciNova

MediciNova Inc.

United States

26 years

2006

11

PROFIT X PRICE MNOV

Financial Results MNOV

MNOV cash flow

Asset, Revenue and Profit Growth - MNOV

MNOV balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions